Last reviewed · How we verify
NCT05813574
Long Term Impact of COVID-19
trial testing Observational patient reported outcomes in Long COVID-19 in 835 participants. Completed in 1 November 2023.
1 October 2023
Quick facts
| Lead sponsor | Medisch Spectrum Twente |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 835 |
| Start date | 28 July 2020 |
| Primary completion | 1 October 2023 |
| Estimated completion | 1 November 2023 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Observational patient reported outcomes
Conditions studied
- Long COVID-19 — all drugs for Long COVID-19 →
- Post-COVID-19 Syndrome — all drugs for Post-COVID-19 Syndrome →
- COVID-19 — all drugs for COVID-19 →
Sponsor
Medisch Spectrum Twente — full company profile →
Who can join
18 and older, any sex, with Long COVID-19 or Post-COVID-19 Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has a devastating effect on human lives, including over 6.6 million death as of November 2022. Furthermore, many individuals continue to experience persisting sequelae after the initial infection. Little is known about the impact of undergoing COVID-19 hospitalisation. Hence, the investigators propose an observational longitudinal study in a cohort of COVID-19 survivors after hospital discharge, to examine their perspectives on their health, health-related quality of life, and persistence of common COVID-19 symptoms, such as fatigue, dyspnoea and anxiety. Potential influencing socio-demographic and biological factors will additionally assessed.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Affect and post-COVID-19 symptoms in daily life: An exploratory experience sampling study.
Schaap G, Wensink M, Doggen CJM, van der Palen J, et al · · 2024 · cited 2× · PMID 39446922 · DOI 10.1371/journal.pone.0295217 -
One-year trajectories of physical and mental health-related quality of life, fatigue and dyspnoea in COVID-19 survivors.
Schaap G, Davelaar JF, Ten Klooster PM, Doggen CJM, et al · · 2025 · cited 1× · PMID 39425867 · DOI 10.1007/s11136-024-03812-y
Verify or expand the search:
- PubMed search for NCT05813574
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Long COVID-19
Currently open trials in the same condition.
- NCT06960928 — Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19 · Phase 3 · recruiting
- NCT06156176 — Pursuing Reduction in Fatigue After COVID-19 Via Exercise and Rehabilitation (PREFACER): A Randomized Feasibility Trial · NA · recruiting
- NCT06404099 — RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia) · Phase 2 · active not recruiting
- NCT06404112 — RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD) · Phase 2 · active not recruiting
- NCT07005947 — Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project · active not recruiting
Other Medisch Spectrum Twente trials
Trials by the same sponsor.
- NCT07486570 — Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery · NA · recruiting
- NCT05941559 — EMDR for Persistent Pain in RA · NA · enrolling by invitation
- NCT06480084 — Prevalence of EILO Among Children With Asthma · NA · not yet recruiting
- NCT06844006 — Investigating the Impact of Nudging Cardiologists to Prescribe Guideline-directed Medical Therapy in Heart Failure Patie · NA · recruiting
- NCT06702735 — The Rainbow Study - the Effect of Feedback on Asthmatic Symptom Perception · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05813574 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medisch Spectrum Twente
- Last refreshed: 25 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05813574.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing